Search company, investor...

PurpleSun

purplesun.com

Founded Year

2011

Stage

Seed VC | Alive

Total Raised

$3M

Last Raised

$3M | 5 yrs ago

About PurpleSun

PurpleSun is a technology company on a mission to transform healthcare by creating the first non-chemical based standard for disinfection.

Headquarters Location

2121 41st Ave Suite 5B

Long Island City, New York, 11101,

United States

Missing: PurpleSun's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PurpleSun's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing PurpleSun

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PurpleSun is included in 1 Expert Collection, including Health Monitoring & Diagnostics.

H

Health Monitoring & Diagnostics

2,530 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

PurpleSun Patents

PurpleSun has filed 1 patent.

The 3 most popular patent topics include:

  • Microbiology
  • Disinfectants
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/27/2019

1/19/2021

Infectious diseases, Epidemiology, Microbiology, Units of length, Bacterial diseases

Grant

Application Date

6/27/2019

Grant Date

1/19/2021

Title

Related Topics

Infectious diseases, Epidemiology, Microbiology, Units of length, Bacterial diseases

Status

Grant

Latest PurpleSun News

Coronavirus company news summary – FDA provides EUA for first point-of-care antibody test – PurpleSun introduces disinfection technology

Sep 24, 2020

24 September 2020 (Last Updated September 24th, 2020 09:37) Share Article The US Food and Drug Administration (FDA) has issued Emergency Use Authorisation (EUA) for the first serology point-of-care test for Covid-19. The test, Assure's Covid-19 IgG/IgM Rapid Test Device, previously received authorized for emergency use by certain labs in July to detect those who developed SARS-CoV-2 antibodies, which indicates recent infection. The FDA has now resissued the EUA to approve the test for POC use with the use of fingerstick blood samples. PurpleSun has introduced its PurpleSun E300 system which uses Focused Multivector Ultraviolet (FMUV) light technology to disinfect within 90secs. The PurpleSun E300 can be used to disinfect equipment and rooms as the people inside continue to work around the system safely. PurpleSun has also partnered with Hackensack Meridian Health and Northwell Health to provide government agencies with the decontamination technology. Vela Diagnostics has received the an EUA from the FDA for its ViroKey SARS-CoV-2 RT-PCR Test v2.0. The test is an automated probe-based reverse transcription PCR test that can identify the Covid-19 causing SARS-CoV-2 virus in nasopharyngeal and oropharyngeal swabs. CLIA certified laboratories in the US can use the test to detect Covid-19. CapsoVision has announced that US Food and Drug Administration will provide enforcement discretion to permit the use of CapsoCam Plus small bowel capsule endoscope for patients amid the Covid0-19 pandemic. With this addendum, fully remote capsule endoscopy procedure can be carried out for eligible patients who are monitored at home. This will eliminate the need for in-person interaction which reduces the risk of infection. Related Companies

PurpleSun Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PurpleSun Rank

PurpleSun Frequently Asked Questions (FAQ)

  • When was PurpleSun founded?

    PurpleSun was founded in 2011.

  • Where is PurpleSun's headquarters?

    PurpleSun's headquarters is located at 2121 41st Ave, Long Island City.

  • What is PurpleSun's latest funding round?

    PurpleSun's latest funding round is Seed VC.

  • How much did PurpleSun raise?

    PurpleSun raised a total of $3M.

  • Who are the investors of PurpleSun?

    Investors of PurpleSun include Northwell Holdings & Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.